Davide Chiasserini

Research interests

Publications

• Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

  Alzheimer s & Dementia · 2024 · 10.1002/alz.13658

• Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration

  Brain · 2019 · 10.1093/brain/awz065

• Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies

  Molecular Neurobiology · 2018 · https://doi.org/10.1007/s12035-018-1090-0

• Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients

  Movement Disorders · 2017 · https://doi.org/10.1002/mds.27136

• Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

  Alzheimer s Research & Therapy · 2017 · https://doi.org/10.1186/s13195-017-0276-4

• Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis

  Movement Disorders · 2017 · https://doi.org/10.1002/mds.27110

• Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links

  Movement Disorders · 2016 · https://doi.org/10.1002/mds.26562

• Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression

  Movement Disorders · 2016 · https://doi.org/10.1002/mds.26754

• A Practical Guide to Immunoassay Method Validation

  Frontiers in Neurology · 2015 · https://doi.org/10.3389/fneur.2015.00179

• Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies

  Molecular Neurodegeneration · 2015 · https://doi.org/10.1186/s13024-015-0010-2

• Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

  Frontiers in Aging Neuroscience · 2014 · https://doi.org/10.3389/fnagi.2014.00053

• Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset

  Journal of Proteomics · 2014 · https://doi.org/10.1016/j.jprot.2014.04.028

• Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease

  Movement Disorders · 2014 · https://doi.org/10.1002/mds.25772

• Effects of central and peripheral inflammation on hippocampal synaptic plasticity

  Neurobiology of Disease · 2013 · https://doi.org/10.1016/j.nbd.2012.12.009

• Cerebrospinal fluid biomarkers in Parkinson disease

  Nature Reviews Neurology · 2013 · https://doi.org/10.1038/nrneurol.2013.10

• Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias

  Movement Disorders · 2011 · https://doi.org/10.1002/mds.23670

• The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

  Alzheimer s & Dementia · 2011 · https://doi.org/10.1016/j.jalz.2011.05.2243

• Mitochondria and the Link Between Neuroinflammation and Neurodegeneration

  Journal of Alzheimer s Disease · 2010 · https://doi.org/10.3233/jad-2010-100543

Current projects

No projects listed.